fund
Artemis Global Growth I
International equity fund run using SmartGARP systematic process.
-
333.99p
Price (Inc)
These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.
-
-
Price (Acc)
These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?
-
1.00% 0.00%
Initial chargeSome funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!
-
0.75%
Annual management charge
This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).
-
0.87%
Ongoing charges
This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.
-
2.10%
Yield
How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…
This fund invests in equities worldwide and usually has a bias to large cap stocks. Run using SmartGARP, Artemis' in-house quantitative stock ranking system, the fund tends to perform best in directional markets but underperform at market turning points, which may make it unsuitable as a core holding. The fund had a strong track record but was downgraded after poor results during and after the banking crisis.
Fund summary
| Sector | Global |
| Structure | UNIT TRUST |
| Launched | March, 2008 |
| Size | £0m |
| Yield | 2.10% |
| Charging basis | Income |
| Dividends paid | Acc units only |
Charges
| Standard initial charge | 1.00% |
| Initial charge via Bestinvest | 0.00% |
| Additional bid/offer spread | 0.00% |
| Annual management charge | 0.75% |
| Ongoing charges figure | 0.87% |
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Investment process
The investment process is based around a quantitative filter known as SmartGARP, a daily process analysing over 100 items of company specific data for each stock, 36 macroeconomic data points and 28 separate sector weightings. The items are systematically split into seven factors the managers have identified as driving stock prices. At its core the fund looks for companies that are mispriced based on valuation and projected growth; another factor looks at quality of earnings. The process also includes earnings estimate revisions and macro-economic data to avoid stocks that are cheap for a reason. The final two factors include momentum and investor sentiment. These factors aid in market timing. The factors, equally weighted except for earnings revisions which are a double weight, are combined to give a score for over 6000 stocks. Though the process is primarily quantitative, the manager authenticates the SmartGARP data using such factors as a company’s news flow and will also take account of diversification in forming the portfolio.
The fund has a strong track record but was downgraded by Bestinvest after poor results during and after the banking crisis. The fund tends to outperform in directional markets but underperform at market turning points, and with the economic outlook still uncertain we have reservations over whether it can recapture its former glories.
Manager research
Average monthly relative returns
- 16/17 -0.24%
- 17/18 0.42%
- 18/19 -0.34%
- 19/20 -0.61%
- 20/21 -0.49%
Bestinvest MRI
- 3 years -0.48%
- 5 years -0.25%
- Career 0.05%
- 3 years 3.10%
- 5 years 12.50%
- Career 88.10%
Performance figures are based on the average of monthly percentage returns relative to the benchmark index.
Peter Saacke
Saacke joined Artemis in December 2002, managing the Artemis European Growth Fund since December 2002 and Artemis Global Growth Fund since January 2004. He joined from Merrill Lynch, where he worked as Pan European equity strategist and quantitative economist from 1999. Prior to this he became a visiting researcher at the European University Institute in Florence. Saacke has a BA in Maths & Philosophy from Oxford University, an MA in Economics from Freiburg University and a PhD in Economics from Hamburg University. He is a CFA charterholder.
Track record
Peter Saacke has 17.1 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been +0.05%. During the worst period of relative performance (from June 2008 - August 2010) there was a decline of 32% relative to the index. The worst absolute loss has been 46%. Statistically, we estimate the probability that this fund manager is adding value, rather than being lucky, is 88%.
Periods of worst performance
| Absolute | -46.00% (October 2007 - February 2009) |
| Relative | -32.00% (June 2008 - August 2010) |
About the MRI
Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Top 10 holdings
Data accurate as at 31 July 2020
| 2.7693% | Apple Inc |
| 1.6426% | Enel Spa |
| 1.5115% | Abbvie Inc |
| 1.4673% | Microsoft Corp |
| 1.4364% | Sanofi |
| 1.4188% | Verizon Communications Inc |
| 1.4083% | Bristol-Myers Squibb Co |
| 1.3801% | Snam Spa |
| 1.2963% | Asr Nederland Nv |
| 1.2721% | Vale Sa |
| Source: Trustnet |
Sector breakdown
| Biotechnology/Medical | 9.00% |
| Materials | 9.00% |
| Capital Goods | 9.00% |
| Banks | 8.00% |
| Utilities | 7.00% |
| Hardware | 6.00% |
| Insurance | 6.00% |
| Automotive | 5.00% |
| Telecommunications Utilities | 5.00% |
| Consumer Durables | 4.00% |
Portfolio
Typically holds around 150-200 stocks, weighted according to their SmartGARP. Approx. 75% of portfolio invested in 75 stocks with av. holding period of 5-6 months.
Constraints
Maximum 5% in an individual holding. Minimum 40% large cap. Sectors limits are +/-10% and regional weights +/- 20%. Any dollar exposure over 25% of the portfolio is hedged.
Key Investor Information